Avience Biomedicals Financials

NSE: AVIENCE

₹342.95

₹-6.65 (-1.90%)

As on 16-Sep-2026 13:29IST

Market cap

₹192 Cr

Revenue (TTM)

₹45 Cr

P/E Ratio

21.9

P/B Ratio

3.6

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	45.24	23.96	--	--	--	--
Total Income	45.97	24.37	--	--	--	--
Total Expenditure	33.79	19.86	--	--	--	--
EBITDA	11.45	4.10	--	--	--	--
Depreciation	0.86	0.62	--	--	--	--
EBIT	10.59	3.49	--	--	--	--
Interest	1.52	0.95	--	--	--	--
Other Income	0.73	0.41	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	9.80	2.95	--	--	--	--
Provision for Tax	2.57	0.80	--	--	--	--
Profit after Tax	7.23	2.14	--	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	7.23	2.14	--	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	22.78	6.21	--	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	10.16	7.51	--	--	--	--
Current Liabilities	23.51	20.82	--	--	--	--
Total Liabilities	56.45	34.54	--	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	19.28	11.50	--	--	--	--
Current Assets	37.17	23.04	--	--	--	--
Total Assets	56.45	34.54	--	--	--	--
Total Debt*	22.16	15.13	--	--	--	--
Net Current Assets	13.66	2.22	--	--	--	--
Contingent Liabilities	0.40	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	3.61	0.99	--	--	--	--
Cash Flow from Investing Activities	-8.81	-4.03	--	--	--	--
Cash from Financing Activities	9.25	2.97	--	--	--	--
Net Cash Inflow / Outflow	4.05	-0.08	--	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	17.94	6.52	--	--	--	--
Cash EPS (₹)	20.07	8.40	--	--	--	--
Adjusted Book Value (₹)	56.50	18.91	--	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	8.95	3.00	--	--	--	--
Free Cash Flow per Share (₹)	-20.12	-13.28	--	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	34.16	18.25	--	--	--	--
ROE (%)	49.90	34.47	--	--	--	--
ROA (%)	15.90	6.20	--	--	--	--
EBIT Margin (%)	23.41	14.55	--	--	--	--
Net Margin (%)	15.73	8.78	--	--	--	--
Cash Profit Margin (%)	17.89	11.51	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	88.77	--	--	--	--	--
EBIT Growth (%)	203.65	--	--	--	--	--
Net Profit Growth (%)	237.76	--	--	--	--	--
EPS Growth (%)	175.19	--	--	--	--	--
Book Value Growth (%)	266.73	--	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.75	4.00	--	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.97	2.44	--	--	--	--
Short term debt to equity ratio	0.50	1.12	--	--	--	--
Current Ratio	1.58	1.11	--	--	--	--
Quick Ratio	1.03	0.51	--	--	--	--
Interest Coverage	7.45	4.10	--	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	38.05	33.76	--	--	--	--
Asset Turnover	0.99	0.69	--	--	--	--
Receivable days	102.08	123.23	--	--	--	--
Inventory Days	102.74	188.80	--	--	--	--
Payable days	86.43	129.93	--	--	--	--
Cash Conversion Cycle	118.39	182.09	--	--	--	--